1. Home
  2. PLX vs BOOM Comparison

PLX vs BOOM Comparison

Compare PLX & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.82

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Logo DMC Global Inc.

BOOM

DMC Global Inc.

HOLD

Current Price

$6.62

Market Cap

124.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLX
BOOM
Founded
1993
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
204.9M
124.4M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
PLX
BOOM
Price
$1.82
$6.62
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$12.00
$8.50
AVG Volume (30 Days)
509.8K
189.5K
Earning Date
11-13-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$61,840,000.00
$618,683,000.00
Revenue This Year
$14.29
N/A
Revenue Next Year
$16.65
$1.52
P/E Ratio
$26.64
N/A
Revenue Growth
35.41
N/A
52 Week Low
$1.32
$5.46
52 Week High
$3.10
$9.92

Technical Indicators

Market Signals
Indicator
PLX
BOOM
Relative Strength Index (RSI) 44.81 53.88
Support Level $1.68 $6.16
Resistance Level $1.78 $6.85
Average True Range (ATR) 0.09 0.29
MACD 0.02 0.15
Stochastic Oscillator 78.57 84.62

Price Performance

Historical Comparison
PLX
BOOM

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: